ophthalmic components that promote tear secretion

TW202639135APending Publication Date: 2026-10-01ROHTO PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115122841
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-12-27
Filing Date
2020-08-07
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079752_001
    Figure TWG2TA001079752_001
  • Figure TWG2TA001079752_002
    Figure TWG2TA001079752_002
  • Figure TWG2TA001079752_003
    Figure TWG2TA001079752_003
Patent Text Reader

Abstract

This invention relates to an ophthalmic composition for promoting tear secretion, which contains 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidine-4-yl)-1,6-diazaspiro[3.4]octane-1-yl]-3-oxopropanenitrile or a salt thereof. none
Need to check novelty before this filing date? Find Prior Art